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Abstract
Background: Global resource needs estimation is a critical part of addressing the HIV/AIDS
epidemic. To generate these estimates knowledge of costs and cost structures is required. The
evidence base for costs of HIV prevention programmes is limited. Even less is known about the
existence of economies scale and whether, as economic theory suggests, average costs form a 'u'-
shaped curve as scale increases. Using an econometric analysis, this paper addresses this question
by estimating marginal costs and economies of scale for HIV prevention programmes for vulnerable
groups in Southern India with different levels of coverage.
Methods: Two hybrid translog-cost functions were estimated. First, expenditure data from 78
state-funded HIV prevention projects in Andhra Pradesh were used to explore the impact of scale,
institutional history and price on costs; second, economic cost data from 16 commercial sex
worker projects across Tamil Nadu and Andhra Pradesh were analysed to additionally assess the
impact of the value of inputs not reported in expenditure data and location. Coefficient estimates
were used to calculate marginal costs and economies of scale.
Results: The econometric model yielded a good fit (R2 = 0.46, p < 0.001 and R2 = 0.79, p < 0.001,
for the expenditure and economic cost datasets, respectively). The economies of scale index was
greater than 1 for both datasets and fell as coverage increased. Analysis of the expenditure data
found economies of scale were not exhausted, with a 0.002% change in total cost for each extra
person reached and an 11% difference in total cost between target group categories. Estimation
using the economic cost data suggests a point of minimum efficient scale at around 1750–2000
people reached, a 0.03% change in total cost for each extra person reached, and 28% lower costs
in Tamil Nadu than Andhra Pradesh.
Conclusion: Econometric analysis of these standardized datasets provides insights into how costs
change with coverage, the impact of project location and nature of the project target group. The
results demonstrate the importance of understanding the nature of the cost function when
designing, budgeting and estimating resource requirements for scaling up coverage of HIV
prevention projects.
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Background
Addressing the HIV epidemic is a priority for governments
and international agencies throughout the world. A com-
prehensive prevention package is a core part of this
response [1]. Estimates for financing the expansion of HIV
prevention services are part of the on-going global
resource needs estimation for HIV/AIDS programmes
[1,2]. Despite this, the costs and cost structures of HIV pre-
vention programmes are still poorly understood [3-9].
Resource requirement estimates for these programmes
rely on scarce evidence and a limited understanding of
what and how different factors might influence average
costs, especially as programmes are expanded [10-13].
Existing studies show that general health service costs are
influenced by scale of activity (the level of output), the
production technology applied (the mix of inputs used in
service delivery), the scope of activities (e.g. the range of
services provided), input prices, levels of efficiency includ-
ing technical inefficiencies, the context and length of time
the service has been provided [14-24]. In the case of scale,
economic theory suggests that as output increases average
costs will first fall and then rise, resulting in a 'u' – shaped
average cost curve. To test such a hypothesis for HIV pre-
vention services estimates of the marginal cost (the
change in total cost with each unit increase in scale) using
a cost function approach are required [14]. However,
standardised data on the cost structures and factors that
might influence changes in average costs, needed to carry
out this type of analysis, have been lacking [3,4,7-
9,20,25].
In India, where 15% of the world's population infected
with HIV are living [13], recent studies have started to pro-
vide insight into the costs of prevention programmes for
commercial sex workers (CSWs), sexually transmitted
infections (STI) clinic services, the prevention of mother
to child transmission (PMTCT) and voluntary counselling
and testing (VCT) services [26-30]. Two of these studies
suggest decreasing average costs or economies of scale
across the ranges of output examined for CSW and VCT
services [26,27]. In contrast, using different data sets,
Guinness et al. found, amongst a range of factors, that
coverage (number of people reached) explained over 50%
of the variation in unit cost of CSW services and, a simple
non-parametric regression analysis, suggested a 'u' –
shaped average cost curve [28]. Finally, Marseille et al's
2007 multinational study indicates rising cost per 1st visit
and cost per mother completing post-test counselling as
output increased for STI clinic and PMTCT services in
India, respectively [30].
The paper presented here goes beyond the simple regres-
sions used in this previous research to estimate an econo-
metric cost function for HIV prevention services. It uses
the CSW cost data presented in Guinness et al [28] and a
new set of data from 78 HIV prevention projects for vul-
nerable groups collected for the present analysis. Marginal
costs for different levels of coverage are calculated to
measure the degree of scale economies in HIV prevention
projects targeted at high risk populations. The impact of
other key contextual factors on total and average costs is
also assessed.
The paper uses data from HIV prevention projects for vul-
nerable groups, a priority for the Indian National AIDS
Control Programme, in Andhra Pradesh and Tamil Nadu,
two Indian states with high levels of prevalence (2.0% and
0.5% of the sampled antenatal clinic population, respec-
tively [31]). The projects are all implemented by local
NGOs contracted by the State AIDS Control Societies
(SACS) (the Tamil Nadu State AIDS Control Society
(TNSACS), Chennai Corporation AIDS Prevention and
Control Society (CAPACS) and Andhra Pradesh State
AIDS Control Society (APSACS) or other agencies (Chris-
tian Council for Rural Development and Research (CCO-
ORR)). The projects comprise a combination of peer
education, promotion of safer sex behaviour, referral for
treatment of STIs, provision or sales of condoms and cre-
ating an environment that facilitates behaviour change,
for example working with community leaders and the
police.
Methods
(i) Data
The sampling frame, sampling methods and data collec-
tion instruments are described in Table 1. The sample
frame comprised existing HIV prevention projects for vul-
nerable groups in Tamil Nadu and Andhra Pradesh. Their
similar implementation approach (a combination of peer
education, condom distribution, referral for STI treatment
and creating an enabling environment) is based on the
National AIDS Control Programme best practice model
[32]. This allows for pooling of the sample across the
states and funding agencies.
Expenditure data, for the financial year 2001/02, from 78
HIV state-funded prevention projects in Andhra Pradesh
were analysed (the financial dataset) to explore the impact
on costs of scale, target group, institutional history and
price. This large sample allowed for statistically robust
results. However, expenditure data do not provide a com-
plete a picture of costs. They include reported recurrent
expenditures which in this case fall in the following cate-
gories: rent, personnel, office running expenses, expenses
associated with specific activities (behaviour change com-
munication & creating an enabling environment), peer
educator incentives, condoms, STI treatment, expenses
incurred by staff to participate in training, travel, monitor-
ing and evaluation and "other." They do not include costs
incurred at the funding agency level, capital investmentsCost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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or donated inputs. As a result a second smaller dataset (the
case study dataset) of economic costs, for 2001/02, from 16
commercial sex worker projects across Tamil Nadu and
Andhra Pradesh was analysed. This allowed the additional
assessment of the impact of costs incurred at the funding
agency level and other inputs not valued in the expendi-
ture data, as well as differences across the states. A detailed
description of the case study dataset is provided elsewhere
[28]. In summary, the additional costs included in the
case study dataset are: the annualised capital costs of train-
ing, development of educational materials, equipment,
furniture and vehicles; monitoring and other managerial
costs incurred at the funding agency level; and, donated
inputs at the project level, including volunteer time, vehi-
cles and building space used by the projects (see table 2).
(ii) Econometric model specification
The cost function estimation followed methods applied in
the hospital cost literature in which total costs are a func-
tion of input prices and output [33-36]. To allow for the
influence of other explanatory variables beyond output
measures, a hybrid functional form was used [33]. This
implies that the cost function is linearly homogenous in
input prices. It was assumed that the NGOs behave in a
cost minimizing way given their constrained budgets.
The equation for the total cost function was therefore:
Where, C = total cost, a0 and a1 are constants; q is output
of the project, x is a vector of independent variables that
shift the cost function and w is a variable representing
input prices. The model has a flexible functional form
with linear, squared and cubed variables in output. Taking
the log of both sides the equation becomes:
Using coefficient estimates, the marginal cost of output is:
MC = C (b1 + 2b2q + 3b3q2)( 3 )
The measurement of marginal cost allows for the calcula-
tion of an index of economies of scale (EOS). Following
Weaver and Deolalikar (2004) and Barnum and Kutzin
(1993) the derived equations for economies of scale are
therefore [14,36]:
Where EOS is the economies of scale index, σa,b is the elas-
ticity of a with respect to b and k is the capital stock. For
this set of cross-sectional data with a single output and in
which variations in capital stock have been controlled for
(see below), this simplifies to:
Economies of scale are the gains in efficiency associated
with the level of output. If EOS is greater than one then
the level of output is less than the most efficient level. If it
is less than one the level of output is greater than the most
efficient level of output. When EOS is equal to one there
are constant returns to scale.
(iii) Variables
Table 2 describes the variables used in the model. The sin-
gle output measure (q) is coverage (the number of mem-
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Table 1: Sampling and methods of data collection for the AP financial dataset and case study datasets used in the cost function 
estimations
Financial dataset Case study dataset§
Sample frame 101 NGO HIV prevention projects implementing 
targeted interventions under contract to APSACS~
40 NGO HIV prevention interventions targeted at commercial sex 
workers and their clients, contracted by CAPACS*, CCOORR**, 
APSACS~ and TNSACS#
Sample size 78 projects from the sampling frame. Exclusion criteria 
related to non response, missing documentation, mis-
reporting in outputs and termination of project
16 purposively selected NGO HIV prevention projects based on 
geographical location, a range of HIV experience and agency 
knowledge of quality of services
Data collection 
instruments
Project reported quarterly expenditure statements 
submitted to and collected from the management agency 
alongside a postal survey of NGOs to collate information 
on coverage and organisational characteristics."
Economic cost and coverage data collected using an ingredients 
approach based on the UNAIDS costing guidelines [44] during 
project visits and using routine monitoring records. Costs also 
include those incurred for technical support, monitoring and 
contractual management costs at the funding and management 
agency levels.
§ For more information about this dataset, see [28]; *Chennai Corporation AIDS Prevention and Control Society; **Christian Council for Rural 
Development and Research; ~ Andhra Pradesh State AIDS Control Society;#Tamil Nadu State AIDS Control Society.Cost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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bers of the target group reached i.e. individuals that have
received HIV prevention services from the project). Other
available measures of output (number of contacts, treated
STIs) are directly related to the level of coverage and each
other. If entered into the model they could cause prob-
lems of multicollinearity. A single price variable (w) was
entered into the model (rent), representing regional varia-
tions in prices of locally purchased goods. Prices of per-
sonnel, drugs and condoms were not needed as they are
set centrally and are constant across the projects [35]. As
input substitution across other inputs (training, building
and office expenses, monitoring and evaluation etc) is
Table 2: Variables used to represent cost, coverage and prices as well as contextual factors influencing the cost of the projects.
Representation in sample (N)
Variable Definition Andhra Pradesh financial dataset (n = 78) Case studies (n = 16)
Total cost Total annual cost of the project Annual expenditure of the project for 
financial year 2001/02 at the NGO level 
(Source: expenditure statements 
submitted to the unit managing all 
NGO projects)
Total annual economic cost 
including costs incurred at the 
funding agency level (training, 
monitoring, other managerial 
support, supply of educational 
materials) and value of volunteer 
time and other donated inputs 
(Source: primary data collection at 
NGOs and funding agencies, see 
also [28]).
Coverage Number of people within the target 
community reached by the project in the 
year of study
Source: postal survey of all projects Source: NGO monitoring reports
Rent Annual rent for buildings paid by the 
NGO for the project
Annual expenditure on rent by the 
project for the year 2001/02
Annual equivalent market value of 
building space used by the project.
Target group High risk group at which project is 
targeted
Commercial sex workers (n = 17); Men 
who have sex with men (n = 2); Street 
children (n = 4); Transgenders (n = 1); 
Truckers (n = 17); Slum populations 
(n = 37)
Commercial sex workers (n = 16)
Vulnerable groups Focus on smaller, relatively static 
populations allowing for more intensive 
interactions with the individuals over 
time
Commercial sex workers (n = 17); Men 
who have sex with men (n = 2); Street 
children (n = 4); Transgenders (n = 1)
n/a
Non-vulnerable groups Focus on larger more mobile 
populations that are still high risk (i.e. 
warranting the targeted intervention) so 
that repeat contacts with individuals are 
less likely
Truckers (n = 17); Slum populations 
(n = 37)
n/a
Funding agency 
(AP financial dataset)
Donor that funded initial recruitment of 
NGO
Department of International 
Development (UK) – DFID (n = 30); 
Andhra Pradesh State AIDS Control 
Society – APSACS (n = 48)
n/a
Funding agency 
(case study dataset)
Donor that is currently funding the 
project
n/a Tamil Nadu State AIDS Control 
Society – TNSACS (n = 4); 
Chennai Corporation AIDS 
Prevention and Control Society – 
CAPACS(n = 2);Christian Council 
for Rural Development and 
Research – CCOORR (n = 2); 
APSACS (n = 9)
Agency Agency that managed initial recruitment 
of NGO and start up of project, grouped 
by batch of recruitment to programme
APSACS1 (n = 22); APSACS2 (n = 26); 
HHP (n = 3); SMA1 (n = 14); SMA2 
(n = 13)
n/a
State Indian state in which project is located n/a Andhra Pradesh – AP (n = 9); Tamil 
Nadu – TN (n = 7)
Age No. of years the project has been 
operating
Source: postal survey of all projects Source: case study analysis
n/a = not applicable; APSACS1 = Andhra Pradesh State AIDS Control Society (APSACS) NGO recruitment batch 1; APSACS2 = APSACS 
recruitment batch 2; HHP = Department of International Development (UK) (DFID) Healthy Highways Project; SMA1 = DFID State Management 
Agency (SMA) recruitment batch 1; SMA2 = DFID SMA NGO recruitment batch 2Cost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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limited, it was valid to exclude all prices except for one,
the cost of rent (rent) representing regional variations in
prices of locally purchased goods[35,37,38]. Although,
this variable is used in the summation of total costs, its
correlation coefficient with total cost was less than 0.6
(Spearman's R = 0.5166, p < 0.001), indicating the rela-
tionship was insufficient to cause major bias.
Contextual factors likely to influence costs included were
target group (target group), contractual history (funding
agency/agency), location of the project (state) and project
age (age) (see table 2). Target group influences costs as
some populations are more difficult to reach than others.
Funding agency/agency captures variations in start-up
input, ongoing training and technical support and so con-
trols for differences in capital stock (see table 2). State was
included to examine the influence of the different settings
on cost. Finally, age can lower average costs through learn-
ing or increase average costs as more experienced workers
demand higher salaries.
(iv) Estimation
The models were estimated using Stata version 8 and ordi-
nary least squares regression. Following equation (2), the
model was first estimated with the linear, squared and
cubic coverage terms:
ln C = a0 + a1w + b1q + b2q2 + b3q3 + c1x1 + c2x2 + c3x3 + c4x4,
(6)
The regressions with higher order terms in coverage were
potentially collinear causing instability in the estimates.
The mean variance inflation factor (VIF) was used to iden-
tify multicollinearity. If the mean VIF for a model is
greater than 1, multicollinearity is said to be a problem
[39]. In the cubic models, the mean VIF's were 503.2 and
79.17 for the case study and financial datasets, respec-
tively. The joint significance of squared and cubic terms in
coverage was tested and found to be insignificant for both
datasets and omitted from the model. A non-significant
result from Ramsey's RESET test for the financial data set
indicated that the new specification was correct (H0: the
model has no omitted variables: F = 0.35, p = 0.9056). The
results of the Ramsey RESET test for the case studies were
more ambiguous (H0: the model has no omitted varia-
bles: F = 3.95, p = 0.0594). The presence of higher order
terms could be rejected at the 95% confidence level. To
examine this further, additional analyses were undertaken
retaining the squared and cubic terms left in the model.
Multicollinearity appeared to affect the estimation by gen-
erating the wrong sign on coverage squared, leading to
negative values of marginal cost. This supported the
choice to exclude the squared and cubic terms on coverage
from the estimation.
The linear version was run with different combinations of
the dummy variables listed in Table 2 and using both
direct values and subsequently natural logs of the inde-
pendent variables. The F statistic on all models run was
significant at the 95% confidence level. The best fit model
was therefore selected based on the value of the adjusted
R2 and whether coefficients on the independent variables
were significant (p < 0.10).
(v) Identifying the best fit model
For the financial dataset, target group was the only factor
beyond price and coverage found to influence the total
cost function. Assuming that agency/funding agency is a
good indicator of the variation in start up costs, the lack of
significance of this variable was interpreted as meaning
that start up costs had little influence on variable costs. As
other capital investment, was minimal, no further control
for capital stock was considered to be required. The final
model specification for the financial dataset was there-
fore:
ln C = a0 + a1 In w + b1q + c1x1,( 7 )
Where x1 is a dummy variable representing vulnerable
group interventions (non-vulnerable group being the
excluded category).
For the case studies, state was the only other factor influ-
encing the cost function significantly. Good fits were
obtained with the direct values of price as well as their nat-
ural log. To facilitate comparability with the analysis of
the financial dataset, the natural log of the price variable
was used. The specification for the case study dataset was
therefore:
ln C = a0 + a1 In w + b1q + c1x1 (8)
Where x1 is a dummy variable representing the state of
Tamil Nadu (Andhra Pradesh being the excluded cate-
gory).
The Cook-Weisberg (Breusch-Pagan) test was used to test
for heteroscedasticity. This was found to be absent in the
final models. Marginal cost and economies of scale were
calculated using equations (3) and (5), respectively, with
the predicted value of cost. To transform the geometric
mean of the logged dependent variable to the arithmetic
mean of the original variable, the average of the exponen-
tial of the residuals was used as a smearing factor so that
[40-42]:
EC e e e
aa w f x q mean resid ()
(,) ( ) =
+ 01 (9)Cost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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Results
(i) Descriptive statistics
Tables 3 and 4 provide descriptive statistics for the data-
sets. Forty CSW projects had been identified across the
two states. For the case study data, 16 were selected purpo-
sively based on location, experience and quality of serv-
ices (see table 1). On average the NGOs selected were
smaller than the total population of projects identified in
terms of total organisation annual expenditures (INR 2.2
million and INR 4.5 million, respectively) and total staff
numbers (27 and 46, respectively). They had a similar
level of experience in the field of HIV, with an average of
5 years working on HIV prevention. It is possible that
there is a bias towards better quality projects as NGOs'
funders were unlikely to invite the research team to poorer
quality sites. This could have led to higher total costs and
coverage.
Within the case study data, there is a significant difference
in mean annual economic cost across state (p < 0.01) and
funding agency (p < 0.10). Coverage is significantly differ-
ent across state but not across funding agency. Average cost
is found to vary significantly across funding agency but not
state. There is also a significant difference in rent between
the two states.
The sampling frame for the financial dataset comprised all
101 projects supported by APSACS at the time of the
study. Of these it was found that 5 were no longer in oper-
ation, documentation was missing for a further 3 and a
further 11 failed to respond to our postal survey. In addi-
tion, in 4 cases, reported coverage variables were in unre-
alistic ranges relative to the town or district population
size, and so were excluded from the study. Due to the lack
of documentation it is not possible to assess whether there
is a systematic difference between these 23 projects and
the 78 finally included in the sample.
In the financial dataset no significant difference across tar-
get groups or agency was found for expenditure, age, or
rent. Only coverage varied significantly across the target
groups and only average expenditure varied across the
agency variable. It appears that there is also a tendency for
total expenditure and rent to vary across the agency varia-
ble (p = 0.185 and 0.168, respectively).
The case study data yielded a mean annual cost of INR
956,641 and coverage of 1,165 as compared with a total
annual expenditure of INR 689,209 and coverage of 5,647
for the financial data (1 USD = 43.53INR [43]). The mean
cost/expenditure per person were INR1,011 and INR 225
for the case study and financial datasets respectively. The
mean annual cost and cost per person reached in the case
study data are 1.4 times and 4.5 times the mean annual
expenditure and expenditure per person derived from the
financial data, respectively.
(iii) Cost function estimates
Goodness of fit
Results from the best-fit regressions for each dataset are
presented in table 5. For the financial dataset, the adjusted
R2 is 0.46 and the F statistic is significant at the 99% con-
fidence level (F = 22.48, p < 0.001). For the case study
dataset the adjusted R2 is 0.79, with a strongly significant
F test (F = 19.71, p < 0.001).
Relationship between coverage and total cost
For each model, the coefficient on coverage is statistically
significant. The relative impact of scale on cost varies
across the datasets. There is a 0.03% change in total cost
for each extra person reached in the case study dataset,
compared with a 0.002% change in total cost for each
extra person reached in the financial dataset.
Marginal costs
The marginal cost at the median level of coverage in the
case study dataset is over 25 times the equivalent value for
the financial dataset (INR335 and INR 13, respectively).
The higher value in the case study data is likely due to the
different shapes of the cost functions as well as the nature
of the data (economic cost in the former and financial cost
in the latter). Marginal cost also varies across coverage lev-
els within each dataset. For the financial dataset (median
coverage = 3,901) the marginal costs are INR 14.26, INR
13 and INR 15.4 at the 25th percentile, median and 75th
percentile of coverage, respectively. Figure 1 shows that
marginal costs increase over the range of coverage for the
financial dataset. For the case studies (median coverage =
1,174 people reached), marginal cost also rises as cover-
age increases (see figure 2): marginal cost at the 75th per-
centile of coverage is 1.9 times that at the 25th percentile
of coverage (INR 450 and INR 227, respectively).
Average cost
Figures 1 and 2 also describe the shape of the predicted
and actual average cost curves. For the financial dataset,
average costs decline at a decreasing rate over the coverage
range. There is an approximately four-fold drop in costs
between coverage levels of 1000 and 5000 people
reached. Average costs are then halved from INR 129 to
INR 65 as coverage increases from 5000 to 15000. Average
costs do not reach a minimum, nor does the marginal cost
curve cross the average cost curve. On the other hand,
average costs in the case study sample suggest there is
some minimum efficient scale of operation for commer-
cial sex worker projects. The average cost is 2.4 times
higher at 500 people reached than at its lowest point at
1750 people reached, falling from INR 1231 to INR 516.C
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Table 3: Sample means of the annual economic cost, coverage, project age and annual rent paid by state and funding agency, from the economic costing of the case studies, N= 16 (range)
State Funding agency
Andhra Pradesh Tamil Nadu t test for 
difference, 
p value
CAPACS* CCOORR** APSACS~ TNSACS# ANOVA for 
difference, 
p value
Total
Annual economic 
cost, INR
956,641 
(474,299–2,220,988)
1,222,151 
(839,664–2,220,988)
615,270 
(474.300–775,062)
0.0016^^^ 726,320 (68,931) 503,776 (41,685) 1,222,151 
(439,036)
610,167 (84,761) 0.059^
No. of people reached 1,165 (205–2008) 1,523 (935–2008) 704 (250–1749) 0.0015^^^ 700 (212) 281 (43) 1,523 (375) 989 (750) 0.173
Cost per person 
reached, INR
1,011.1(414.5–2,133) 806.3 (563.2–1,106.1) 1,274.4 
((414.5–2,133)
0.9675 1071.9 
(911.8–1232.0)
1829.0 
(152501–2133.0)
806.3 
(563.2–1106.1)
1039.5 
(414.5–2082.5)
0.026
Project age, yrs 7.1 (3.3–13.0) 7.00 (3–13) 7.29 (4–12) 0.5628 9.00 (4.2) 5.50 (0.7) 7.00 (3.8) 7.00 (2.9) 0.596
Rent 48,660(15,135–80,700) 57,525 (30,697–77,840) 37,262 
(15,135–80,700)
0.0261^^ 58,350 (31,608) 17,468 (3,298) 57,525 (16,857) 37,650 (5,529) 0.202
Sample size 16 9 7 2 2 8 4
*Chennai Corporation AIDS Prevention and Control Society; **Christian Council for Rural Development and Research; ~ Andhra Pradesh State AIDS Control Society; #Tamil Nadu State AIDS Control Society; 
^^^significant at the 99% confidence level; ^^significant at the 95% confidence level; ^significant at the 90% confidence level.
Table 4: Sample means of the annual expenditure, coverage, project age and annual rent paid by target group and agency, from the Andhra Pradesh financial dataset (N = 78) (range)
Target group* "Agency": Management agency at recruitment of NGO & batch of recruitment **
Total Non-vulnerable Vulnerable t test, 
p value
APSACS1 APSACS2 HHP SMA1 SMA2 ANOVA 
p value
Total 
expenditure 
INR 000s
689.2 
(40.85–1,581)
663.8 
(40.85–1,581)
746.3 
(528.1–1,246.9)
0.9375 677.1 
(40.9–1,457.3)
639.2 (418.3–1,581) 822.2 (474.4–1,091) 767.3 
(467.5–1,247)
695.0 
(528.1–1,046)
0.185
No. of people 
reached
5,647 
(675–24,111)
6,809 (993–24,111) 3,034 (675–14,871) 0.0004^^^ 6,611 (993–13,955) 6,064 (1,027–17,614) 18,624 
(14,390–24,111)
3,479 
(1,555–14,871)
2,525 (675–7,099) 0.255
Expenditure 
per person 
reached, INR
224.5 
(11.6–939.1)
143.0 (11.6–592.6) 408.0 (74.3–939.1) 1.000 139.5 (11.6–529.0) 147.7 (35.4–592.6) 46.8 (27.3–75.8) 314.8 
(74.3–748.4)
466.0 
(107.0–939.1)
0.000^^^
Project age, 
yrs***
2.72 (2.1–5.6) 2.60 (2.1–5.6) 3 (2.1–3.92) 0.9724 2.5 (0) 2.25 (0) 5.59 (0) 3.92 (0) 2.08 (0) n/a
Rent, INR 48,480 (0–90,338) 44,937 (0–71,540) 56,452 
(31,399–90,338)
0.997 44,542 (0–61,891) 45,057 
(19,905–65,388)
48,699 
(29,680–71,541)
56,164 
(31,281–72,677)
53,664 
(43,059–90,338)
0.168
Sample size 78 54 24 22 26 3 14 13
*"Vulnerable group" projects include those for commercial sex workers (CSW), street children (SC), transgenders (TG) and men who have sex with men (MSM); "Non vulnerable group" projects are those for 
truckers, mobile populations and slum dwellers. ** Prior to 2001, the targeted interventions were funded and managed by 3 different projects – Andhra Pradesh State AIDS Control Society (APSACS); Department 
for International Development UK (DFID) supported Healthy Highways Project (HHP); and the DFID supported State Management Agency (SMA). The dummies represent these 3 different projects and that both 
APSACS and SMA recruited NGOs in 2 separate batches.***Projects started at the same time within each "agency" group. ^^^significant at the 99% confidence level; ^^significant at the 95% confidence level; 
^significant at the 90% confidence level.Cost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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Average cost then rises again to 727 INR at 2000 people
reached.
Economies of scale
EOS is greater than 1 for both the datasets across the inter-
quartile range of coverage. This indicates that economies
of scale are not exhausted over this output range. The EOS
falls from 21.29 (CI = 14.02–36.75) for the 25th percentile
value of coverage (2451), to 7.01 (CI = 4.82–12.69) at the
75th  percentile (7099). The fall in EOS as coverage
increases, as well as the shape of the average cost curve,
also suggests that as coverage increases the projects are
moving towards greater scale efficiency (see figure 1). For
the case study data the economies of scale appear to be
exhausted within the range of coverage analysed (at the
maximum value of coverage (2008), EOS = 1.4 (CI =
0.8–5.6)).
Average, predicted average and marginal cost, INR, of targeted HIV prevention projects – financial dataset Figure 1
Average, predicted average and marginal cost, INR, of targeted HIV prevention projects – financial dataset. 
Blue diamond: Actual average cost. Pink square: Predicted average cost. White triangle: Marginal cost.
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Table 5: Cost function estimates
Variable AP financial data Case studies
Coefficient Standard error Coefficient Standard error
Constant 8.053843* 0.909046 11.55254* 0.718119
Ln(price) 0.4827907* 0.0849852 0.1729654** 0.0627868
Coverage 2.01 × 10-5 *4 . 5 2  ×  1 0 -6 0.000347** 0.000127
Vulnerable group 0.1143** 0.04873
Tamil Nadu -0.2801** 0.12508
N7 6 § 16
F 22.48* 19.71*
Adjusted R2 0.4622 0.7891
Test for heteroscedasticity 
(χ2(1))
5.81** 3.29***
Additional tests
*significant at 99%; **significant at 95%; ***significant at 90%; § Two cases are dropped as rent = 0Cost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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Impact of non-scale factors on cost
The estimation shows that costs also vary with location
and target group. For the case studies, the coefficient on
state is negative and significant (p = 0.045), i.e. costs are
28% lower in Tamil Nadu than Andhra Pradesh. For the
financial dataset, including target group improves model
fit (p = 0.0220), indicating that the "vulnerable" group
interventions are 11% higher in total cost than the "non-
vulnerable" group interventions.
Price also has a positive and significant relationship with
total cost (p = 0.017 for the case study dataset, p < 0.001
for the financial dataset). Costs are therefore price inelas-
tic so that a 1% increase in price leads to a rise in costs of
0.48% and 0.17% increase in costs in the financial and
case study datasets, respectively.
The model including agency was rejected as the adjusted
R2 was lower than in the model including state. However
the high adjusted R2  and significance of the model
(adjusted R2 = 0.7887, p < 0.001) led to the perception
that agency could impact on costs. The rejected model was
therefore run using the case study data i.e. including
agency and excluding state. The new model found total
costs of the TNSACS and CAPACS projects were 54% (p =
0.021) and 47% (p = 0.043) less than the APSACS
projects, respectively.
Discussion
This paper has presented the econometric estimation of a
cost function for HIV prevention services using two sets of
data. Results generated from the datasets are similar: there
are differences in costs across the targeted interventions
associated with scale and local prices. For the case study
data, the analysis found that there were scale efficiencies
to be exploited. These appear to be exhausted at a cover-
age level of between 1750–2000 CSWs reached. Although
the up turn in the average cost curve is driven by only two
data points, the EOS index shows projects with higher lev-
els of coverage are operating with close to constant returns
to scale. The model based on the financial dataset found
that economies of scale are not exhausted even at higher
levels of coverage. In addition, differences between target
groups are an important influence on cost. Total cost of
vulnerable group projects are on average 11% higher than
for the non-vulnerable group. This change in the intercept
in the relationship between cost and coverage implies
higher fixed costs in the vulnerable group projects. This is
likely to reflect greater difficulty in reaching the more mar-
ginalized groups represented in vulnerable group projects
(e.g. CSWs, men who have sex with men) and requiring
greater investment in initiating the project, in particular in
establishing a relationship with the community. When
agency is included in the model, the case study data also
Average, predicted average and marginal cost, INR, of targeted HIV prevention projects – case study dataset Figure 2
Average, predicted average and marginal cost, INR, of targeted HIV prevention projects – case study dataset. 
Blue diamond: Actual average cost. Pink square: Predicted average cost. White triangle: Marginal cost.
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confirms a difference in the production costs between
funding agencies.
This analysis represents the first of its kind for HIV preven-
tion programmes. However, it does have limitations. In
both cases, the datasets are cross-sectional. This precludes
examination of time effects on cost e.g. lagged cost or
lagged coverage and leads to a possible bias in results. The
quality of the case study data has been discussed else-
where[28]. The small size of this data set could affect the
level of significance of the different models tested in the
selection of the best fit. Despite the limited data, the F sta-
tistic on all models was significant at the 95% confidence
level. The financial dataset is subject to misreporting.
However as the NGOs are unable to exceed the agreed
budget this is most likely to affect the proportion of
spending on individual line items rather than the total
reported expenditure used here. In the present analysis,
coverage is considered to be exogenous. Targets are fre-
quently not met and are based on estimates of target pop-
ulation size. In addition, although budgetary guidelines,
issued by the National AIDS Control Programme, have
the potential to restrict flexibility [32], it is believed that
there is sufficient variation in costs to warrant the econo-
metric approach. Budget setting involves NGO consulta-
tion, consideration of the previous years' activities and the
budgets granted deviate from the guidelines. A concern
remains that pre-determined costs and outputs lead to
bias in the regression coefficients [35].
The results from the financial and case study datasets are
striking for both their similarities and differences. The
best-fit functional form is almost identical across the two
datasets. Both display some potential for economies of
scale. There is a major difference in the coefficients on
coverage in the regressions, i.e. the proportionate change
in cost associated with an additional person reached. This
results in the steeper marginal cost curve generated from
the case study data. Along with the 'u' – shape of the aver-
age cost curve, seen in the case study data analysis, this
could arise from a number of factors. First, the range of
coverage in the financial dataset (675–24,111 people
reached) is far greater than in the case study dataset
(250–2008 CSWs reached). Second, definitions of total
cost vary. The economic costing (case study dataset) incor-
porates the value of volunteer time, the value of all inputs
irrespective of the funding source and the inputs of train-
ing, monitoring and supervision and management made
by the funding or management agency. Together these
contain the value of a number of fixed inputs. Theoreti-
cally, it is fixed costs that are responsible for increases in
average costs as scale increases. As a result, the inclusion
of these fixed costs in the case study dataset is likely to
have important implications for the differences in mar-
ginal cost and economies of scale as coverage increases
across the datasets. Third, it may be harder to reach CSWs
beyond the limit of the population within a specific geo-
graphical location, giving rise to an increase in fixed costs.
Finally, the appropriate functional form for the case stud-
ies may not in fact coincide with that for the financial
dataset. The more ambiguous results of the Ramsey RESET
test for the case study model indicate that either higher
order terms or interactions of the dummies with output
may have been omitted. However, persistent problems
with multicollinearity did not permit stable estimation
with higher order terms and the small sample precluded
the inclusion of interaction terms.
Kumaranayake and Watts (2000), using cost data from a
range of HIV/AIDS prevention and care programmes,
found that projects are likely to encounter diseconomies
of scale arising from infrastructural barriers as coverage
increases [5]. The analysis of the case study data reinforces
these more general findings and suggests a point of mini-
mum efficient scale. On the other hand, results from the
financial dataset indicate continuing economies of scale,
at least over the range examined here. These support the
findings of Dandona et al in examining the economics
costs of HIV prevention for commercial sex workers also
in India (coverage range = 803–6379) [26]. The differing
results could be associated with the wider range of cover-
age. They also suggest that the case study analysis may
reflect the impact of bottlenecks that can be addressed in
the long run. If this is the case, the coverage level at which
fundamental changes in the fixed costs are required in
order to improve efficiency as activities are scaled up is
therefore around 1750–2000. The paper adds to a grow-
ing literature which finds contrasting results on costs and
scale in the area of HIV prevention [5,26-28,30]. These
differences and the influence of the contextual factors,
identified here, underline the importance of full eco-
nomic costing and the understanding of a project's con-
text when planning and estimating resource
requirements.
Conclusion
This paper presents the estimation of a cost function for
HIV prevention services using two datasets, using a flexi-
ble functional form. The combination of the two stand-
ardised datasets and econometric techniques has
provided greater insights into how costs change with cov-
erage and the key factors that influence total costs. The
findings indicate there are economies of scale as coverage
increases. The case study dataset suggests that, in terms of
scale efficiency, it would be optimal for a project to oper-
ate at a coverage in the region of 1750–2000 sex workers.
The financial dataset suggest that large scale projects are
more efficient than small scale projects with a 5 fold
increase in coverage level (1000 to 5000 people reached)
leading to four fold drop in average cost. The results alsoCost Effectiveness and Resource Allocation 2007, 5:13 http://www.resource-allocation.com/content/5/1/13
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show that local price variations, the project target group
and location are important influences on average cost.
The analysis demonstrates the importance of understand-
ing the nature of the cost function in designing project
contracts, selecting efficient levels of coverage for these
projects, constructing their respective budgets and for esti-
mating resource requirements for scaling up coverage of
HIV prevention projects.
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